Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
03.01. | IRLAB Therapeutics - End-of-Phase II FDA meeting set | 461 | Edison Investment Research | IRLAB Therapeutics has scheduled an end-of-Phase II (EoP2) meeting (on 20 February 2024) with the US FDA for the mesdopetam programme. This marks an important milestone for IRLAB as it will evaluate... ► Artikel lesen | |
03.01. | Sequana Medical - PMA application submitted to FDA for alfapump | 356 | Edison Investment Research | Sequana Medical announced in late December that it has submitted a Premarket Approval (PMA) application to the US FDA regarding its alfapump device for use in patients with recurrent and refractory... ► Artikel lesen | |
03.01. | Sareum Holdings - SRA737 - new partnership to kick off the year | 373 | Edison Investment Research | Sareum Holdings' co-development partner CRT Pioneer Fund (CPF) has signed a new licensing agreement with an unnamed US-based private biopharma company for SRA737, its Phase II stage CHK1 inhibitor targeting... ► Artikel lesen |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
SUPER MICRO COMPUTER | 3.922 |
EVOTEC | 3.139 |
TUI | 2.772 |
NVIDIA | 2.686 |
BAYER | 2.637 |
NEL | 2.417 |
RENK GROUP | 1.767 |
RHEINMETALL | 1.679 |
TESLA | 1.275 |
VOLKSWAGEN | 1.246 |
PALANTIR TECHNOLOGIES | 1.245 |
DEUTSCHE BANK | 1.133 |
PLUG POWER | 1.050 |
MICROSTRATEGY | 1.031 |
BYD | 1.027 |
AMAZON | 1.023 |
BASF | 1.011 |
PROSIEBENSAT.1 | 1.010 |
COMMERZBANK | 1.007 |
MERCEDES-BENZ | 931 |
THYSSENKRUPP | 927 |
ALLIANZ | 873 |
JINKOSOLAR | 871 |
DEUTSCHE TELEKOM | 866 |
AIXTRON SE | 859 |